Assessment of the Impact of Statin Use to Predict All-Cause Mortality in Patients With Critical Cerebrovascular Disease: A Retrospective Cohort Study From the MIMIC-IV Database.

Although pravastatin and rosuvastatin calcium also showed trends toward reduced mortality, these associations did not reach statistical significance in the HS subgroup, likely due to smaller sample sizes (e.g., Pravastatin HS‐30‐day HR 0.55, 95% CI 0.22–1.36, p = 0.19) (Table 3 ).

also in 111,027 other papers